Filing Details

Accession Number:
0001209191-23-058709
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-12-14 20:58:32
Reporting Period:
2023-12-13
Accepted Time:
2023-12-14 20:58:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1231457 Genelux Corp GNLX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1939103 John Thomas C/O Genelux Corporation
2625 Townsgate Road, Suite 230
Westlake Village CA 91361
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-12-13 7,073 $13.23 465,387 No 4 S Direct
Common Stock Disposition 2023-12-13 1,927 $13.93 463,460 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The weighted average sale price for the transaction reported was $13.2261, and the range of prices were between $12.76 and $13.75. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  2. The weighted average sale price for the transaction reported was $13.9277, and the range of prices were between $13.80 and $14.13. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.